Microarray Core Facility achieves Illumina CSPro status

The Norwegian Microarray Consortium Oslo (NMC-Oslo) has recently successfully finished the certification for Illumina CSPro for gene expression. This status was obtained after a rigorous certification process. The Rikshospitalet/University of Oslo Microarray Core Facility is the second facility in Europe to achieve this certification.



Press relase from the NMC-Oslo:

The Rikshospitalet/University of Oslo Microarray Core Facility Announces Illumina CSPro Certification for Gene Expression

Oslo, 20th of October 2008 - The Rikshospitalet/University of Oslo Microarray Core Facility announced today that it has successfully completed Illumina CSProTM certification for Gene Expression, gaining entry to an elite group of Illumina genomics service providers globally. Illumina Inc., a San Diego-based company, provides leading-edge genetic analysis tools to genomics centers worldwide.

Illumina CSPro is the collaborative service provider partnership dedicated to ensure the delivery of the highest-quality data available for genetic analysis applications. Illumina CSPro participants undergo a rigorous two-phase certification process that includes minimum data generation, data certification, and an on-site audit of the facility and processes.

QUOTE FROM PROVIDER

"Illumina CSPro recognizes organizations that provide customers with industry-leading data quality and service in genetic analysis," said Karen Possemato, Illumina's Director of Corporate Marketing. "The Rikshospitalet/University of Oslo Microarray Core Facility is now a certified service provider in Norway able to deliver gene expression services using Illumina technology. Now that the Rikshospitalet/University of Oslo Microarray Core Facility is a global CSPro partner, we are excited to work with them to make it easier for researchers in Norway and the Nordic countries to access the power of Illumina's genetic analysis technologies."

ABOUT PROVIDER

The Rikshospitalet/University of Oslo Microarray Core Facility is one of the founding members of the Norwegian Microarray Consortium, and has for the last 10 years provided the Norwegian and European community with microarrays and microarray services. Today Rikshospitalet/University of Oslo Microarray Core Facility is running the National Microarray Technology Platform under the Functional Genomic Program of the Research Council of Norway.

More information at uio.microarray.no

Download press release in Word format